Cross syndrome
(Redirected from Oculocerebral-hypopigmentation syndrome)
Cross syndrome is a rare genetic disorder characterized by a combination of physical and neurological abnormalities. It is named after the physician who first described the condition. The syndrome is typically diagnosed in infancy or early childhood.
Symptoms[edit | edit source]
Individuals with Cross syndrome may exhibit a variety of symptoms, including:
- Developmental delay
- Intellectual disability
- Hypotonia (reduced muscle tone)
- Distinctive facial features such as a broad forehead, wide-set eyes, and a small chin
- Congenital heart defects
- Seizures
- Feeding difficulties
Causes[edit | edit source]
Cross syndrome is caused by mutations in a specific gene located on a particular chromosome. The exact genetic mechanism can vary, but it often involves a de novo mutation, meaning it occurs spontaneously and is not inherited from either parent.
Diagnosis[edit | edit source]
Diagnosis of Cross syndrome typically involves a combination of:
- Clinical evaluation
- Genetic testing
- Imaging studies such as MRI or CT scan
- Electroencephalogram (EEG) to assess for seizure activity
Treatment[edit | edit source]
There is no cure for Cross syndrome, and treatment is primarily supportive and symptomatic. Management strategies may include:
- Physical therapy to improve muscle tone and coordination
- Occupational therapy to assist with daily living skills
- Speech therapy to address communication difficulties
- Medications to control seizures and other symptoms
- Surgical interventions for congenital heart defects or other structural abnormalities
Prognosis[edit | edit source]
The prognosis for individuals with Cross syndrome varies widely depending on the severity of symptoms and the presence of associated conditions. Early intervention and supportive care can significantly improve the quality of life for affected individuals.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
-
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD